Continuing Coverage of FDA’s Crackdown on Stem Cell Clinics: Florida Clinic Cited for Unapproved Marketing and Inadequate Sterility Assurance
Unburden Yourself: FDA Requests Comments on Ways to Implement President Trump’s Regulatory Reform Executive Orders
FDA Seizes Stem Cell Therapy—A First of Many?
Do the Waive – FDA Implements Informed Consent Waivers for Minimal Risk Studies
Follow the Money: FDA Issues New Procedures for Evaluating Financial Ties Between Application Sponsors and Clinical Investigators
To certify or not to certify? FDA has answered the question
Ready, Set… Cures Act Expanded Access Policy Deadline is Almost a Go
HHS Overhauls the Common Rule to Enhance Protection for Human Subjects in Research
Short-Fuse Compliance Deadline for Expanded Access Provision in 21st Century Cures Act
Subscribe: Subscribe via RSS
Blogs
Firm/Org